Rustenbeck I - Search Results

1

Triggering and amplification of insulin secretion by dimethyl alpha-ketoglutarate, a membrane permeable alpha-ketoglutarate analogue.

Willenborg M, Panten U, Rustenbeck I. Willenborg M, et al. Among authors: rustenbeck i. Eur J Pharmacol. 2009 Apr 1;607(1-3):41-6. doi: 10.1016/j.ejphar.2009.02.014. Epub 2009 Feb 20. Eur J Pharmacol. 2009. PMID: 19233162

2

2-ketoglutarate generation in pancreatic B-cell mitochondria regulates insulin secretory action of amino acids and 2-keto acids.

Lenzen S, Schmidt W, Rustenbeck I, Panten U. Lenzen S, et al. Among authors: rustenbeck i. Biosci Rep. 1986 Feb;6(2):163-9. doi: 10.1007/BF01115002. Biosci Rep. 1986. PMID: 3521757

3

Transamination of 3-phenylpyruvate in pancreatic B-cell mitochondria.

Lenzen S, Rustenbeck I, Panten U. Lenzen S, et al. Among authors: rustenbeck i. J Biol Chem. 1984 Feb 25;259(4):2043-6. J Biol Chem. 1984. PMID: 6142039 Free article.

4

Energetic requirement of insulin secretion distal to calcium influx.

Rustenbeck I, Herrmann C, Grimmsmann T. Rustenbeck I, et al. Diabetes. 1997 Aug;46(8):1305-11. doi: 10.2337/diab.46.8.1305. Diabetes. 1997. PMID: 9231655

5

Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells.

Rustenbeck I, Herrmann C, Ratzka P, Hasselblatt A. Rustenbeck I, et al. Naunyn Schmiedebergs Arch Pharmacol. 1997 Sep;356(3):410-7. doi: 10.1007/pl00005070. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9303581

6

Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria.

Grimmsmann T, Rustenbeck I. Grimmsmann T, et al. Among authors: rustenbeck i. Br J Pharmacol. 1998 Mar;123(5):781-8. doi: 10.1038/sj.bjp.0701663. Br J Pharmacol. 1998. PMID: 9535004 Free PMC article.

7

No evidence for PKC activation in stimulation of insulin secretion by phentolamine.

Rustenbeck I, Köpp M, Polzin C, Hasselblatt A. Rustenbeck I, et al. Naunyn Schmiedebergs Arch Pharmacol. 1998 Sep;358(3):390-3. doi: 10.1007/pl00005269. Naunyn Schmiedebergs Arch Pharmacol. 1998. PMID: 9774228

8

Heterogeneous characteristics of imidazoline-induced insulin secretion.

Rustenbeck I, Leupolt L, Kowalewski R, Hasselblatt A. Rustenbeck I, et al. Naunyn Schmiedebergs Arch Pharmacol. 1999 Mar;359(3):235-42. doi: 10.1007/pl00005347. Naunyn Schmiedebergs Arch Pharmacol. 1999. PMID: 10208311

9

Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. I. Secretory and morphological studies.

Rustenbeck I, Winkler M, Jörns A. Rustenbeck I, et al. Biochem Pharmacol. 2001 Dec 15;62(12):1685-94. doi: 10.1016/s0006-2952(01)00792-4. Biochem Pharmacol. 2001. PMID: 11755122

10

Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies.

Rustenbeck I, Dickel C, Grimmsmanns T. Rustenbeck I, et al. Biochem Pharmacol. 2001 Dec 15;62(12):1695-703. doi: 10.1016/s0006-2952(01)00793-6. Biochem Pharmacol. 2001. PMID: 11755123

Prolonged in vitro exposure (18 h) of pancreatic islets to insulin secretagogues that block ATP-dependent K(+) channels (K(ATP) channels), such as sulfonylureas, imidazolines, and quinine, induced a desensitization of insulin secretion (Rustenbeck et al., pages 1685-1694, …

Prolonged in vitro exposure (18 h) of pancreatic islets to insulin secretagogues that block ATP-dependent K(+) channels (K(ATP) channels), s …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page